Inhibition of HIV and HSV infection by vaginal lactobacilli in vitro and in vivo

DARU, Journal of Pharmaceutical Sciences

Volumn 20, Issue 1, 2012, Pages

  Zabihollahi, Rezvan ^a   Motevaseli, Elahe ^b   Sadat, Seyed Mehdi ^a   Azizi Saraji, Ali Reza ^a   Asaadi Dalaie, Sogol ^a   Modarressi, Mohammad Hossein ^b  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

HIV; HSV; Lactobacillus; Sexually transmitted disease

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTIBIOTIC AGENT; PROBIOTIC AGENT;

ANIMAL EXPERIMENT; ANTIVIRAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GROWTH INHIBITION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IC 50; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; LACTOBACILLUS; LACTOBACILLUS CRISPATUS; LACTOBACILLUS FERMENTUM; LACTOBACILLUS GASSERI; LACTOBACILLUS RHAMNOSUS; LIFE CYCLE; MOUSE; NONHUMAN; SKIN DEFECT; SUPERNATANT; VAGINA; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN;

EID: 84869390545     PISSN: 15608115     EISSN: 20082231     Source Type: Journal    
DOI: 10.1186/2008-2231-20-53     Document Type: Article

References (27)

1. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. Martin HL, Richardson BA, Nyange PM, Lavreys L, Hillier SL, Chohan B, Mandaliya K, Ndinya-Achola JO, Bwayo J, Kreiss J, J Infect Dis 1999 180 1863 1868 10.1086/315127 10558942
2. Diagnosis and management of bacterial vaginosis and other types of abnormal vaginal bacterial flora: a review. Donders G, Obstet Gynecol Surv 2010 65 462 473 10.1097/OGX.0b013e3181e09621 20723268
3. Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review. Barrons R, Tassone D, Clin Ther 2008 30 453 468 10.1016/j.clinthera.2008.03.013 18405785
4. Findings associated with recurrence of bacterial vaginosis among adolescents attending sexually transmitted diseases clinics. Brotman RM, Erbelding EJ, Jamshidi RM, Klebanoff MA, Zenilman JM, Ghanem KG, J Pediatr Adolesc Gynecol 2007 20 225 231 10.1016/j.jpag.2006.11.009 17673134
5. Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand. Cohen CR, Duerr A, Pruithithada N, Rugpao S, Hillier S, Garcia P, Nelson K, AIDS 1995 9 1093 1097 10.1097/00002030-199509000- 00017 8527084
6. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Sewankambo N, Gray RH, Wawer MJ, Paxton L, McNaim D, Wabwire-Mangen F, Serwadda D, Li C, Kiwanuka N, Hillier SL, Rabe L, Gaydos CA, Quinn TC, Konde-Lule J, Lancet 1997 350 546 550 10.1016/S0140-6736(97)01063-5 9284776
7. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. Atashili J, Poole C, Ndumbe PM, Adimora AA, Smith JS, AIDS 2008 22 1493 1501 10.1097/QAD.0b013e3283021a37 18614873
8. Risk factors for infection with herpes simplex virus type 2: role of smoking, douching, uncircumcised males, and vaginal flora. Cherpes TL, Meyn LA, Krohn MA, Hillier SL, Sex Transm Dis 2003 30 405 410 10.1097/00007435-200305000- 00006 12916131
9. Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women. Watts DH, Fazzari M, Minkoff H, Hillier SL, Sha B, Glesby M, Levine AM, Burk R, Palefsky JM, Moxley M, Ahdieh-Grant L, Strickler HD, J Infect Dis 2005 191 1129 1139 10.1086/427777 15747249
10. Association between bacterial vaginosis and Herpes simplex virus type-2 infection: implications for HIV acquisition studies. Nagot N, Ouedraogo A, Defer MC, Vallo R, Mayaud P, Van de Perre P, Sex Transm Infect 2007 83 365 368 10.1136/sti.2007.024794 17493979
11. Genital tract shedding of herpes simplex virus type 2 in women: effects of hormonal contraception, bacterial vaginosis, and vaginal group B Streptococcus colonization. Cherpes TL, Melan MA, Kant JA, Cosentino LA, Meyn LA, Hillier SL, Clin Infect Dis 2005 40 1422 1428 10.1086/429622 15844064
12. Association between genital tract cytomegalovirus infection and bacterial vaginosis. Ross SA, Novak Z, Ashrith G, Rivera LB, Britt WJ, Hedges S, Schwebke JR, Boppana AS, J Infect Dis 2005 192 1727 1730 10.1086/497150 16235170
13. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial. Zuckerman RA, Lucchetti A, Whittington WL, Sanchez J, Coombs RW, Zuniga R, Magaret AS, Wald A, Corey L, Celum C, J Infect Dis 2007 196 1500 1508 10.1086/522523 18008230
14. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. Corey L, Wald A, Celum CL, Quinn TC, J Acquir Immune Defic Syndr 2004 35 435 445 10.1097/00126334- 200404150-00001 15021308
15. Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. Sha BE, Zariffard MR, Wang QJ, Chen HY, Bremer J, Cohen MH, Spear GT, J Infect Dis 2005 191 25 32 10.1086/426394 15592999
16. Viricidal effect of Lactobacillus acidophilus on human immunodeficiency virus type 1: possible role in heterosexual transmission. Klebanoff SJ, Coombs RW, J Exp Med 1991 174 289 292 10.1084/jem.174.1.289 1647436
17. A novel eukaryotic cell culture model to study antiviral activity of potential probiotic bacteria. Botic T, Klingberg TD, Weingartl H, Cencic A, Int J Food Microbiol 2007 115 227 234 10.1016/j.ijfoodmicro.2006.10.044 17261339
18. Probiotic Lactobacilli for urogenital health in women. Reid G, J Clin Gastroenterol 2008 42 Suppl 3 Pt 2 234 S236 18685506
19. Targeting the vaginal microbiota with probiotics as a means to counteract infections. Reid G, Dols J, Miller W, Curr Opin Clin Nutr Metab Care 2009 12 583 587 10.1097/MCO.0b013e328331b611 19741517
20. Probiotic use of lactobacilli in the human female urogenital tract. McGroarty JA, FEMS Immunol Med Microbiol 1993 6 251 264 10.1111/j.1574-695X. 1993.tb00337.x 8499891
21. Martin MC, Pant N, Ladero V, Gunaydin G, Krogh Andersen K, Alvarez B, Martinez N, Alvarez MA, Hammarstrom L Appl Environ Microbiol: Marcotte H. Integrative expression system for delivery of antibody fragments by lactobacilli 2011
22. Evaluation of the in vitro antiretroviral potential of some Biginelli-type pyrimidines. Zabihollahi R, Vahabpour R, Hartoonian C, Sedaghati B, Sadat SM, Soleymani M, Ranjbar M, Fassihi A, Aghasadeghi MR, Memarian HR, Salehi M, Acta Virol 2012 56 11 18 10.4149/av-2012-01-11 22404604
23. Designing a non-virulent HIV-1 strain: potential implications for vaccine and experimental research. Rezaei A, Zabihollahi R, Salehi M, Moghim S, Tamizifar H, Yazdanpanahi N, Amini G, Journal of research in medical sciences 2007 12 227 234
24. Development of single-cycle replicable human immunodeficiency virus 1 mutants. Zabihollahi R, Sadat SM, Vahabpour R, Aghasadeghi MR, Memarnejadian A, Ghazanfari T, Salehi M, Rezaei A, Azadmanesh K, Acta virologica 2011 55 15 22 10.4149/av-2011-01-15 21434701
25. Sadat SM, Zabihollahi R, Vahabpour R, Azadmanesh K, Javadi F, Siadat SD, Memarnejadian A, Parivar K, Khanahmad Shahreza H, Arabi Mianroodi R, Hekmat S, Aghasadeghi MR, Designing and biological evaluation of single-cycle replicable HIV-1 system as a potential vaccine strategy. 20th European Congress of Clinical Microbiology and Infectious Diseases Austria: Clinical Microbiology and Infection 2010 334
26. Acetone, ethanol and methanol extracts of Phyllanthus urinaria inhibit HSV-2 infection in vitro. Yang CM, Cheng HY, Lin TC, Chiang LC, Lin CC, Antiviral Res 2005 67 24 30 10.1016/j.antiviral.2005.02.008 15885815
27. Inhibition of herpes simplex virus type 2 by vaginal lactobacilli. Conti C, Malacrino C, Mastromarino P, J Physiol Pharmacol 2009 60 Suppl 6 19 26 20400787